Imdevimab

Tax included
Imdevimab (REGN10987) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Imdevimab lacks efficacy against COVID-19 variants. Imdevimab can be used in combination with Casirivimab (HY-P99341), it reduces viral load and improves diseases.
HY-P99342

Data sheet

Size
Multiple sizes
Reactivity
SARS-CoV
CAS
2415933-40-1